OPEN END TURBO OPTIONSSCHEIN LONG - COOPER COMPANIES Share Price

Certificat

DE000GQ8YZX5

Real-time BOERSE MUENCHEN 12:05:51 23/05/2024 am IST
0.414 EUR -0.96% Intraday chart for OPEN END TURBO OPTIONSSCHEIN LONG - COOPER COMPANIES
Current month+126.23%
1 month+81.58%
Date Price Change
22/24/22 0.414 -0.96%
21/24/21 0.418 -7.11%
20/24/20 0.45 +1.35%
17/24/17 0.444 -5.53%
15/24/15 0.47 +22.40%

Real-time BOERSE MUENCHEN

Last update May 23, 2024 at 12:05 am IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying THE COOPER COMPANIES, INC.
Issuer Goldman Sachs
WKN GQ8YZX
ISINDE000GQ8YZX5
Date issued 14/11/2023
Strike 85.8 $
Maturity Unlimited
Parity 25 : 1
Emission price 0.08
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.861
Lowest since issue 0.049

Company Profile

The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision and CooperSurgical. CooperVision is engaged in the contact lens industry. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys, Biofinity toric & Biofinity XR toric, Biofinity multifocal, Biofinity toric multifocal, clariti 1 day, clariti 1 day toric, clariti 1 day multifocal, MiSight 1 day, Avaira Vitality and Avaira Vitality toric. CooperSurgical is a fertility and women’s health company dedicated to assisting women, babies and families around the world. CooperSurgical provides a range of products and services with an emphasis on improving fertility solutions, empowering office-based care, and advancing hospital care within women’s health. CooperSurgical’s brands include Paragard, ER-Complete, Fetal Pillow, INSORB, PGT-Complete, RUMI II and others.
Sector
-
More about the company

Ratings for The Cooper Companies, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: The Cooper Companies, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
96.6 USD
Average target price
107.9 USD
Spread / Average Target
+11.69%
Consensus